Sepsis and multiple organ dysfunction syndrome as the first clinical presentation of Wilson's disease: case report
-
Published:2022-12-01
Issue:5-6
Volume:76
Page:686-690
-
ISSN:2255-890X
-
Container-title:Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
-
language:en
-
Short-container-title:
Author:
Zeltiņa Indra12, Dreimane Katrīne3, Paeglīte Sandra3, Derovs Aleksejs132
Affiliation:
1. Rīga East University Hospital , 2 Hipokrāta Str ., Rīga, LV-1038 , Latvia 2. Department of Infectology , Rīga Stradiņš University , 16 Dzirciema Str., Rīga, LV-1007 , Latvia 3. Department of Internal Diseases , Rīga Stradiņš University , 16 Dzirciema Str., Rīga, LV-1007 , Latvia
Abstract
Abstract
Wilson’s disease (WD) is a rare autosomal recessive disorder caused by a mutation in the ATP7B gene. The evolution of Wilson’s disease is the result of the accumulation of copper in affected tissues. In this study, we report on a 30-year-old patient with multiple organ dysfunction syndrome and sepsis. After the necessary investigations and genetic tests, the patient was diagnosed with WD. Unfortunately, the first symptoms appeared at least ten years ago with elevated liver transaminases and amenorrhea. It is possible that if any of the previous physicians had provided a detailed examination, the patient would have reached a diagnosis sooner. The patient received adequate penicillamine treatment and her condition improved. The patient manages to have a healthy child by slightly changing the treatment of Wilson's disease. This case demonstrates that proper examination and collection of anamnesis information can lead to a diagnosis of WD. In addition, we emphasise the importance of targeted testing for elevated transaminases, especially if the patient has amenorrhea at reproductive age. Wilson's disease is not a barrier to carrying a healthy child. Of course, more research is needed to develop the best treatment and disease management plans.
Publisher
Walter de Gruyter GmbH
Reference12 articles.
1. Cho, Y.-H., Jeong, D.-W., Lee, S.-Y., Park, S.-K., Yoon, K.-T., Kim, Y.-J., Lee, J.-K., Lee, Y.-H. (2011). A case of Wilson's disease in patient with mildly elevated liver enzymes. Korean J. Fam. Med., 32 (3), 205–208. DOI: 10.4082/kjfm.2011.32.3.205.10.4082/kjfm.2011.32.3.205338312522745856 2. European Association for the Study of the Liver (2012). EASL Clinical Practice Guidelines: Wilson’s disease. J. Hepatol., 56 (3), 671–685. DOI: 10.1016/j.jhep.2011.11.007.10.1016/j.jhep.2011.11.00722340672 3. Fabregues, O. De., Viñas, J., Palasí, A., Quintana, M., Cardona, I., Auger, C., Vargas, V. (2020). Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series. Brain Behav., 10 (5), e01596. DOI:10.1002/brb3.1596.10.1002/brb3.1596721824732202078 4. Ferenci, P., Litwin, T., Seniow, J., Czlonkowska, A. (2015). Encephalopathy in Wilson disease: Copper toxicity or liver failure? J. Clin. Exp. Hepatol., 5 (Suppl 1), S88–S95. DOI: 10.1016/j.jceh.2014.09.002.10.1016/j.jceh.2014.09.002444286226041965 5. Hayashi, H., Watanabe, K., Inui, A., Kato, A., Tatsumi, Y., Okumura, A., Fujisawa, T., Kato, K. (2019). Alanine aminotransferase as the first test parameter for Wilson's disease. J. Clin. Transl. Hepatol., 7 (4), 293–296. DOI:10.14218/JCTH.2019.00042.10.14218/JCTH.2019.00042694321631915597
|
|